期刊文献+

人类K562细胞系中组蛋白修饰的调控分析 被引量:1

Regulation of Histone Modifications in K562 Cell Line of Human Beings
下载PDF
导出
摘要 利用10种组蛋白修饰和1种组蛋白变体的ChIP-seq数据,统计了K562细胞系和GM12878细胞系中11种组蛋白修饰在癌基因启动子区域的分布.比较了两个细胞系中致癌基因和抑癌基因启动子区域的组蛋白修饰分布密度,并计算了11种组蛋白修饰与基因表达的相关性,分别在致癌基因和抑癌基因中构建了组蛋白修饰和基因表达的多元线性回归方程,从而发现K562细胞系中癌症发生过程中组蛋白修饰的调控特征.最后对K562细胞系中超级增强子调控的致癌基因和抑癌基因进行GO功能分析,研究这些基因的生物学功能,进一步找出K562细胞系中癌症发生的5个关键基因GATA1、GATA2、H3F3B、LYL1和SH_2B3. Using the ChIP-seq data of 10 kinds of histone modifications and 1 kind of histone variant,the distributions of 11 kinds of histone modifications are computed in the cancer promoter region for K562 cell line and GM12878 cell line.The histone modification densities of oncogenes and tumor suppressor genes in promoter region are compared in the two cell lines.And the correlations of various histone modifications and gene expressions are calculated,and multiple linear regression equations for histone modifications and gene expressions are constructed in oncogenes and tumor suppressor genes respectively.The regulation mode of histone modifications during the carcinogenesis is analyzed.Finally,the GO functions analysis of the regulation role of super-enhancer in the oncogenes and tumor suppressor genes in K562 cell line are made.Based on biological function research of these genes,five key genes GATA1,GATA2,H3 F3 B,LYL1 and SH_2 B3 with carcinogenesis are further identified in K562 cell line.
作者 孟建军 李前忠 MENG Jian-jun;LI Qian-zhong(School of Physical Science and Technology, Inner Mongolia University, Hohhot 010021 ,China)
出处 《内蒙古大学学报(自然科学版)》 CAS 北大核心 2017年第6期625-632,共8页 Journal of Inner Mongolia University:Natural Science Edition
基金 国家自然科学基金资助项目(31460234 11647310)
关键词 组蛋白修饰 致癌基因 抑癌基因 GO分析 histone modification oncogenes tumor suppressor gene GO analysis
  • 相关文献

参考文献1

二级参考文献18

  • 1Yu Jindan,Yu Jianjun,Rhodes Daniel R,Tomlins Scott A,Cao Xuhong,Chen Guoan,Mehra Rohit,Wang Xiaoju,Ghosh Debashis,Shah Rajal B,Varambally Sooryanarayana,Pienta Kenneth J,Chinnaiyan Arul M.A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. Cancer Research . 2007
  • 2Eun Ji Oh,Woo Ick Yang,June-Won Cheong,Sung-eun Choi,Sun Och Yoon.Diffuse large B-cell lymphoma with histone H3 trimethylation at lysine 27: another poor prognostic phenotype independent of c-Myc/Bcl2 coexpression[J]. Human Pathology . 2014 (10)
  • 3Zhigang Xie,Wee Joo Chng,Dong Soon Lee.MMSET: Role and Therapeutic Opportunities in Multiple Myeloma[J]. BioMed Research International . 2014
  • 4William D. Bradley,Shilpi Arora,Jennifer Busby,Srividya Balasubramanian,Victor S. Gehling,Christopher G. Nasveschuk,Rishi G. Vaswani,Chih-Chi Yuan,Charlie Hatton,Feng Zhao,Kaylyn E. Williamson,Priyadarshini Iyer,Jacqui Méndez,Robert Campbell,Nico Cantone,Shivani Garapaty-Rao,James E. Audia,Andrew S. Cook,Les A. Dakin,Brian K. Albrecht,Jean-Christophe Harmange,Danette L. Daniels,Richard T. Cummings,Barbara M. Bryant,Emmanuel Normant,Patrick Trojer.EZH2 Inhibitor Efficacy in Non-Hodgkin’s Lymphoma Does Not Require Suppression of H3K27 Monomethylation[J]. Chemistry & Biology . 2014 (11)
  • 5Hyun Jung Lee,Dong Hoon Shin,Kyung Bin Kim,Nari Shin,Won Young Park,Jung Hee Lee,Kyung Un Choi,Jee Yeon Kim,Chang Hun Lee,Mee Young Sol.Polycomb protein EZH2 expression in diffuse large B-cell lymphoma is associated with better prognosis in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone[J]. Leukemia & Lymphoma . 2014 (9)
  • 6Jianhe Chen,Jing Li,Qin Han,Zhao Sun,Jing Wang,Shihua Wang,Robert C H Zhao.Enhancer of zeste homolog 2 is overexpressed and contributes to epigenetic inactivation of p21 and phosphatase and tensin homolog in B-cell acute lymphoblastic leukemia[J]. Experimental Biology and Medicine . 2012 (9)
  • 7Christina R. Majer,Lei Jin,Margaret Porter Scott,Sarah K. Knutson,Kevin W. Kuntz,Heike Keilhack,Jesse J. Smith,Mikel P. Moyer,Victoria M. Richon,Robert A. Copeland,Tim J. Wigle.A687V EZH2 is a gain-of-function mutation found in lymphoma patients[J]. FEBS Letters . 2012 (19)
  • 8Cerchietti, Leandro C,Hatzi, Katerina,Caldas-Lopes, Eloisi,Yang, Shao Ning,Figueroa, Maria E,Morin, Ryan D,Hirst, Martin,Mendez, Lourdes,Shaknovich, Rita,Cole, Philip A,Bhalla, Kapil,Gascoyne, Randy D,Marra, Marco,Chiosis, Gabriela,Melnick, Ari.BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy[J]. Journal of Clinical Investigation . 2010 (12)
  • 9Jürg Müller,Craig M. Hart,Nicole J. Francis,Marcus L. Vargas,Aditya Sengupta,Brigitte Wild,Ellen L. Miller,Michael B. O’Connor,Robert E. Kingston,Jeffrey A. Simon.Histone Methyltransferase Activity of a Drosophila Polycomb Group Repressor Complex[J]. Cell . 2002 (2)
  • 10Morin Ryan D,Johnson Nathalie A,Severson Tesa M,Mungall Andrew J,An Jianghong,Goya Rodrigo,Paul Jessica E,Boyle Merrill,Woolcock Bruce W,Kuchenbauer Florian,Yap Damian,Humphries R Keith,Griffith Obi L,Shah Sohrab,Zhu Henry,Kimbara Michelle.Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin. Nature Genetics . 2010

共引文献11

同被引文献41

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部